Shares of HIMS experienced a dramatic drop today following the unexpected withdrawal of its agreement with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending HIMS's stock price plummeting by more than 10%. The reason for the dissolution of the partnership remains un